Skip to content

RGEN

Repligen Corporation

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$167.60
−1.19%
Ask drillr
0
Insider buys (3m)
3
Insider sells (3m)
-$1.2M
Net value (3m)
+37.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 2, 2026Hughes Violetta · officer: CHIEF ACCOUNTING OFFICERA-Award2,466$0.00
Sep 2, 2026Hughes Violetta · officer: CHIEF ACCOUNTING OFFICERF-InKind277$170
Aug 21, 2026Loeillot Olivier · director, officer: Chief Executive OfficerSale5,426$180
Aug 21, 2026Loeillot Olivier · director, officer: Chief Executive OfficerM-Exempt5,426$142
Jul 17, 2026Garland Jason K · officer: CFOSale530$150
Jun 26, 2026Garland Jason K · officer: CFOSale733$145
May 18, 2026BARTHELEMY NICOLAS · directorA-Award2,239$103
May 18, 2026Madaus Martin D · directorA-Award2,239$103
May 18, 2026BARTHELEMY NICOLAS · directorA-Award995$0.00
May 18, 2026Mhatre Rohin · directorA-Award2,239$103
May 18, 2026Konstantinov Konstantin · directorA-Award2,239$103
May 18, 2026Mhatre Rohin · directorA-Award995$0.00
May 18, 2026Madaus Martin D · directorA-Award995$0.00
May 18, 2026EGLINTON MANNER CARRIE · directorA-Award995$0.00
May 18, 2026DAWES KAREN A · directorA-Award2,239$103
May 18, 2026Konstantinov Konstantin · directorA-Award995$0.00
May 18, 2026EGLINTON MANNER CARRIE · directorA-Award2,239$103
May 18, 2026Pax Margaret · directorA-Award2,239$103
May 18, 2026Pax Margaret · directorA-Award995$0.00
May 18, 2026MUIR GLENN P · directorA-Award2,239$103
May 18, 2026DAWES KAREN A · directorA-Award995$0.00
May 18, 2026MUIR GLENN P · directorA-Award995$0.00
May 8, 2026MUIR GLENN P · directorM-Exempt2,434$39
May 8, 2026Douglass Brian Robb · officer: CHIEF PRODUCT OFFICERF-InKind334$126
Apr 22, 2026Loeillot Olivier · director, officer: Chief Executive OfficerSale3,832$140
Mar 23, 2026Loeillot Olivier · officer: Chief Executive OfficerA-Award25,890$142
Mar 23, 2026Bylund James · officer: Chief Operating OfficerA-Award7,751$0.00
Mar 23, 2026KURIYEL RALF · officer: Senior VP, R&DA-Award5,669$142
Mar 23, 2026KURIYEL RALF · officer: Senior VP, R&DA-Award5,284$0.00
Mar 23, 2026Loeillot Olivier · officer: Chief Executive OfficerA-Award24,134$0.00
Institutional positioning

13F filings over the trailing two quarters

New 166Increased 341Reduced 280Sold out 57
FilerActionSharesFiled
BLACKROCK, INC.Reduced5,993,054May 13, 2026
BlackRock, Inc.Reduced5,384,938Aug 7, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased4,878,141May 15, 2026
FMR LLCIncreased3,326,690Aug 13, 2026
FMR LLCIncreased2,886,786May 15, 2026
UNITED CAPITAL FINANCIAL ADVISORS, LLCIncreased2,790,650Aug 17, 2026
UNITED CAPITAL FINANCIAL ADVISERS, LLCIncreased2,773,980May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,411,171Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,396,511May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased2,312,825Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position2,305,094May 8, 2026
MAVERICK CAPITAL LTDIncreased1,984,554Aug 14, 2026
STATE STREET CORPIncreased1,800,530Aug 7, 2026
STATE STREET CORPIncreased1,777,285May 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/Reduced1,752,274Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026